Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology

By LabMedica International staff writers
Posted on 02 Aug 2018
Sysmex (Kobe, Japan) celebrated its 50th anniversary at this year’s annual meeting of the American Association for Clinical Chemistry (AACC) and shared its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology. More...
The AACC 2018 held July 29 – August 2 in Chicago, Illinois, USA, was attended by approximately 20,000 clinical laboratory professionals from more than 110 countries.

Sysmex offers clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. The company is innovating across all of its diagnostic practices, including flow cytometry, urinalysis and hematology.

At AACC 2018, Sysmex showcased its first fully automated urine particle analyzer, which reduces the need for manual slide review and delivers first-pass accuracy and unprecedented workflow efficiency. Sysmex’s UN series consists of three analyzer modules and is the first fully configurable urinalysis solution to offer expanded parameters. In addition to being configurable to meet the needs of every laboratory, Sysmex’s solution will allow laboratorians to focus more time on analyzing test results.

Visitors to the Sysmex booth were able to view the company’s new comprehensive flow cytometry system which is highly automated and features a broad portfolio of CyFlow anti-body reagents and the PS-10 sample preparation system with automated cell wash. The new product also includes the XF-1600 flow cytometer with multi-colored capability, high sample throughput and software solutions for the most difficult samples. Sysmex also displayed its FDA-cleared XN-20 complete blood count (CBC) analyzer, a complementary system to its XN-10.

Also on display at Sysmex’s booth at AACC was the automated GloCyte cell counter system, which provides an unprecedented detection level for automated cerebrospinal fluid (CSF) cell counts. Sysmex also showcased its first-of-its-kind XW-100, the world’s first CLIA-waived CBC analyzer that can provide three-part blood test results in as few as three minutes, allowing patients to get answers faster and their physicians to develop treatment plans more quickly.

“As we celebrate five decades of providing laboratories around the world with highly accurate, efficient and dependable diagnostic solutions, we are excited about what we have in store for the laboratory of the future,” said Ralph Taylor, chief executive officer of Sysmex America. “The path to better healthcare is through better testing and Sysmex is lighting the way.”

“Laboratories are facing growing staffing and reimbursement challenges,” said Andy Hay, chief operating officer of Sysmex America. “Sysmex is developing innovative solutions that increase efficiency and allow clinical laboratory professionals to do the work that both ignites their passion for diagnostics and leads to the greatest impact on patient care.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.